In the context of CBT for BED, GLP-1RAs are considered an adjunctive approach for patients with coexisting higher weight when traditional behavioral and psychological interventions alone are insufficient to manage binge-eating behaviors and support weight management
Is a weight-loss plateau after several months a sign the medication has stopped working
[00:06:14] Emily Field: In the major clinical trials for Glide and Tirzepatide participants experienced average weight losses in the range of 15 to 22% of body weight, which is quite significant compared to traditional lifestyle interventions alone
Ozempic and Wegovy are the brand names for semaglutide and are the same medication
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: post-hoc analysis
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections